Monashee Investment Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History
Bought
Maintained
Sold
Other funds holding NAMSW
Monashee Investment Management's NAMSW Position: Q4 2024 in Review
Monashee Investment Management sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q4 2024, closing a stake of 31,189 shares — an estimated $218K sold.
Monashee Investment Management first reported a position in NAMSW in Q1 2024 and held it in 2 quarters. The position peaked at $344K in Q1 2024. 11 funds tracked by Wall St. Rank hold NAMSW as of Q4 2024.
- Monashee Investment Management reported no remaining NewAmsterdam Pharma Warrant position as of Q4 2024 after selling out during the quarter.
- Monashee Investment Management sold 31,189 NewAmsterdam Pharma Warrant shares in Q4 2024, an estimated $218K.
- Monashee Investment Management first reported a position in NewAmsterdam Pharma Warrant in Q1 2024 and held it in 2 quarters.
- Monashee Investment Management's NewAmsterdam Pharma Warrant position peaked at $344K in Q1 2024.
- 11 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q4 2024.
Based on Monashee Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.